PMID: 8958912Oct 31, 1996Paper

Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo

Annals of the New York Academy of Sciences
M K GatelyD H Presky

Abstract

Mo(p40)2 is a potent IL-12 antagonist that interacts strongly with the beta 1 subunit of the IL-12R to block binding of moIL-12 to the high-affinity mouse IL-12R. Mo(p40)2, alone or in synergy with the 2B5 mAb specific for the moIL-12 heterodimer, blocked IL-12-induced responses in vitro, Mo(p40)2 was thus used alone or with 2B5 mAb to examine the role of IL-12 in vivo, Mo(p40)2 caused a dose-dependent inhibition of both the rise in serum IFN-gamma levels in mice injected with endotoxin and the Th1-like response to immunization with KLH. Treatment with mo(p40)2 plus 2B5 anti-moIL-12 mAb also suppressed DTH responses to methylated bovine serum albumin but not specific allogeneic CTL responses in vivo. In each of these models, responses seen in mice treated with mo(p40)2 +/- 2B5 anti-moIL-12 mAb were similar to those observed in IL-12 knockout mice. Thus, mo(p40)2 can act as a potent IL-12 antagonist in vivo, as well as in vitro, and is currently being used to investigate the role of IL-12 in the pathogenesis of some Th1-associated autoimmune disorders in mice.

References

Jan 1, 1995·European Journal of Immunology·S GillessenM K Gately
May 1, 1993·The Journal of Experimental Medicine·F P HeinzelM K Gately
Jan 16, 1996·Journal of Immunological Methods·V L WilkinsonD H Presky
Sep 1, 1995·Research in Immunology·D H PreskyM K Gately

❮ Previous
Next ❯

Citations

Jul 31, 1998·Clinical Immunology and Immunopathology·R R Caspi
Sep 29, 2006·Folia Microbiologica·I LomákováL Prokesová
Sep 21, 2002·Lancet·Andrew Sandford, Peter Paré
Jan 5, 2002·Veterinary Immunology and Immunopathology·Ann Marie WhiteCynthia L Baldwin
Oct 18, 2002·Veterinary Immunology and Immunopathology·G I Solano-AguilarJ K Lunney
Sep 2, 2003·Cytokine & Growth Factor Reviews·Wendy T WatfordJohn J O'Shea
Jul 21, 2012·Nature Immunology·Dario A A Vignali, Vijay K Kuchroo
Oct 27, 2001·Clinical and Experimental Immunology·J Sirois, E Y Bissonnette
Oct 29, 2000·European Journal of Biochemistry·E MartensK Vandenbroeck
Mar 14, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Y ZhangI N Mbawuike
Aug 17, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·G PiazzollaS Antonaci
Aug 22, 2002·The Journal of Clinical Investigation·Burkhard BecherRandolph J Noelle
Sep 4, 2003·The Journal of Clinical Investigation·Christoph BeckerMarkus F Neurath
May 19, 2010·International Journal of Molecular Sciences·Therwa HamzaBingyun Li
Nov 24, 2011·International Journal of Biological Sciences·Douglas J PerkinsJohn Michael Ong'echa
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M PützerF L Graham
Apr 28, 2006·International Journal of Radiation Biology·Hae-Ran ParkSang-Gi Paik
Jul 28, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Doo-Jin KimYoung-Chul Sung
Sep 21, 2001·The Journal of Investigative Dermatology·T KoppT S Kupper
Oct 20, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·John M Ong'echaDouglas J Perkins
Nov 28, 2006·Trends in Immunology·Andrea M Cooper, Shabaana A Khader
Apr 8, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yongxia WuXue-Zhong Yu
Feb 22, 2005·The Journal of Pharmacy and Pharmacology·I Alloza, K Vandenbroeck
May 17, 2007·International Journal of Immunogenetics·S StanilovaG Prakova
Jul 27, 2006·Scandinavian Journal of Immunology·K AbdiP Matzinger
Apr 6, 2016·Frontiers in Molecular Neuroscience·Nora BedrossianYoussef Fares
Jul 18, 2015·Cytokine & Growth Factor Reviews·Sebastian Zundler, Markus F Neurath
Sep 19, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Patricia Méndez-Samperio
Dec 8, 1998·International Journal of Health Services : Planning, Administration, Evaluation·G Pappas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.